🇺🇸 FDA
Pipeline program

Hylenex

HZ2-05-06

Phase 3 small_molecule completed

Quick answer

Hylenex for Pain is a Phase 3 program (small_molecule) at HALOZYME THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
HALOZYME THERAPEUTICS, INC.
Indication
Pain
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials